Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsRent ExpenseShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Acadia Healthcare Company (ACHC) Accumulated Depreciation & Amortization (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $1.0 billion as the latest value for Q1 2026.

  • For Q1 2026, Accumulated Depreciation & Amortization rose 11.16% year-over-year to $1.0 billion; the TTM value through Mar 2026 reached $1.0 billion, up 11.16%, while the annual FY2025 figure was $1.0 billion, 12.24% up from the prior year.
  • Accumulated Depreciation & Amortization hit $1.0 billion in Q1 2026 for Acadia Healthcare Company, up from $1.0 billion in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.0 billion in Q1 2026 and bottomed at $569.5 million in Q1 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $805.5 million, with a median of $796.7 million recorded in 2024.
  • Year-over-year, Accumulated Depreciation & Amortization rose 21.92% in 2022 and then increased 11.16% in 2026.
  • Acadia Healthcare Company's Accumulated Depreciation & Amortization stood at $656.6 million in 2022, then grew by 16.87% to $767.3 million in 2023, then increased by 16.78% to $896.1 million in 2024, then grew by 12.24% to $1.0 billion in 2025, then rose by 4.17% to $1.0 billion in 2026.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $1.0 billion, $1.0 billion, and $975.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.